The pulmonary arterial hypertension treatment market is poised for significant growth, with a projected worth of US$ 5,811.5 million by 2023, surging to US$ 7,224.4 million by 2033. A compound annual growth rate (CAGR) of 2.2% during the forecast period underscores steady advancement in treatment options and patient care. Key Market Trends and Highlights: In …
Tag Archives: Pulmonary Arterial Hypertension Treatment Market Trends
Pulmonary Arterial Hypertension Treatment Market, Poised to Surpass a Noteworthy US$ 6.6 Billion by 2028-FMI Projection
The pulmonary arterial hypertension (PAH) treatment industry stands as a beacon of hope for individuals grappling with this rare but serious condition that affects the heart and lungs. PAH involves abnormally high blood pressure in the arteries that connect the heart and lungs, leading to reduced blood flow and strain on the heart. The treatment landscape for …